Altrafin AG’s Salesforce CRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-13,381
Closed -$3.54M 54
2025
Q4
$3.54M Hold
13,381
1.12% 22
2025
Q3
$3.17M Buy
13,381
+1,037
+8% +$262K 1.01% 26
2025
Q2
$3.37M Buy
12,344
+20
+0.2% +$5.35K 1.14% 25
2025
Q1
$3.31M Buy
12,324
+2,739
+29% +$852K 1.29% 25
2024
Q4
$3.2M Hold
9,585
1.11% 30
2024
Q3
$2.62M Buy
9,585
+3,142
+49% +$805K 0.95% 30
2024
Q2
$1.66M Buy
+6,443
New +$1.72M 0.61% 35

Other funds holding CRM

Altrafin AG's CRM Position: Q1 2026 in Review

Altrafin AG sold out of Salesforce (CRM) in Q1 2026, closing a stake of 13,381 shares — an estimated $3.54M sold.

Altrafin AG first reported a position in CRM in Q2 2024 and held it in 7 quarters. The position peaked at $3.54M in Q4 2025. 2,686 funds tracked by Wall St. Rank hold CRM as of Q1 2026.

  • Altrafin AG reported no remaining Salesforce position as of Q1 2026 after selling out during the quarter.
  • Altrafin AG sold 13,381 Salesforce shares in Q1 2026, an estimated $3.54M.
  • Altrafin AG first reported a position in Salesforce in Q2 2024 and held it in 7 quarters.
  • Altrafin AG's Salesforce position peaked at $3.54M in Q4 2025.
  • 2,686 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.

Based on Altrafin AG's 13F filing for Q1 2026, filed 14 Apr 2026.